Dynamic analysis of pathogenic distribution and drug resistance mechanism in neonatal suppurative meningitis: a

Lu He1, Muchun Yu1, Zhihong Sun1

  • 1Department of Neonatology, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, Henan Province, 450000, China.

PubMed
Abstract

Insights

Neonatal meningitis cases declined post-2020, with evolving pathogen distribution and drug resistance patterns. Continuous surveillance is crucial for effective antimicrobial stewardship and treatment strategies.

Area of Science:

  • Neonatal infectious diseases
  • Microbiology
  • Epidemiology

Background:

  • Neonatal purulent meningitis presents significant morbidity and mortality.
  • Increasing antibiotic resistance necessitates updated treatment strategies.
  • Pathogen distribution and resistance mechanisms evolve, requiring continuous monitoring.

Purpose of the Study:

  • To analyze dynamic changes in pathogenic distribution and drug resistance in neonatal suppurative meningitis.
  • To compare trends between preterm and full-term neonates.
  • To inform antimicrobial stewardship and optimize antibiotic treatments.

Main Methods:

  • Retrospective analysis of neonatal suppurative meningitis cases (2017-2022).
  • Inclusion criteria: positive cerebrospinal fluid cultures.
  • Analysis of pathogenic distribution and drug resistance mechanisms over time and by neonatal group.

Main Results:

  • Significant bacterial pathogens included Staphylococcus epidermidis, Klebsiella pneumoniae, Escherichia coli, and Enterococcus faecium.
  • Klebsiella pneumoniae proportion varied significantly across years (P=0.025).
  • Carbapenem-resistant Enterobacteriaceae (CRE) and methicillin-resistant coagulase-negative staphylococci (MRCNS) showed significant yearly differences (P=0.016 and P=0.031). MRCNS (22.8%) and CRE (16.5%) were the most prevalent drug-resistant bacteria.

Conclusions:

  • Neonatal suppurative meningitis incidence decreased annually from 2020-2022, post-COVID-19 pandemic.
  • Enterococcus faecium incidence was higher pre-pandemic; MRCNS increased post-pandemic.
  • The pandemic influenced pathogen and drug-resistant bacteria distribution, highlighting the need for ongoing surveillance.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
220
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
548